By comparison, increased SF3B6 expression was significantly negatively related to apoptosis and tumor immunity-related pathways, such as complement activation, oxidative phosphorylation, allograft rejection, heme metabolism, NF-κB/TNF-α signaling, coagulation, interferon-gamma response, and interferon-alpha response. The gene discussed is SF3B6; the disease is neoplasm.